CDH2 and breast cancer: Treatment of MCF-7 breast cancer cells (which have a metastatic tumor cell phenotype) with anti-NGAL antibodies prevented changes in E/N-cadherin expression relative to their control33 and anti-NGAL antibody administration decreased lung metastasis in a mouse model of breast cancer23.